News
INVO Bioscience Regains Full U.S. Commercialization Rights
SARASOTA, Fla., Nov. 8, 2021 -- INVO Bioscience, Inc. ("INVO" or the "Company") (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo culture system (IVC), today announced it will regain full U.S. commercialization rights for its...
INVO Bioscience Announces Four Individual Poster Abstracts Discussing the Benefits of INVOcell Presented at the 2021 American Society for Reproductive Medicine (ASRM) Congress & Expo
SARASOTA, Fla. and BALTIMORE, Oct. 20, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOcell®, an effective and affordable treatment for patients...
INVO Bioscience Announces Grand Opening of “Positib Fertility, an INVO Center” in Monterrey, Mexico on November 1, 2021
Positib Fertility, an INVO Center, becomes first international JV-owned clinic focused on providing INVOcell to assist the underserved patients in need of advanced fertility careSARASOTA, Fla. and MONTERREY, Mexico, Oct. 14, 2021 -- INVO Bioscience, Inc. (NASDAQ:...
INVO Bioscience Announces $4.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
SARASOTA, Fla., Oct. 1, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo culture system (IVC), INVOcell®, today announced that it has entered into definitive agreements with institutional...
INVO Bioscience Advances INVOcell® Commercialization Efforts With Acquisition in Canada
Provides platform to leverage the existing INVOcell product registration in Canada and ongoing work with leading embryologist, Ric Ross, to establish INVO Centers and enhance distribution into existing fertility clinicsSARASOTA, Fla., Sept. 9, 2021 -- INVO Bioscience,...
INVO Bioscience Announces Official Opening of “Bloom Fertility, an INVO Center” in Atlanta
Bloom Fertility, An INVO Center becomes the second JV-owned clinic focused on providing INVOcell to assist the underserved patients in need of advanced fertility careSARASOTA, Fla. and ATLANTA, Sept. 7, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device...
Dr. Inger Britt Carlsson, Vice President of Global Medical Affairs for INVO Bioscience, to Present at the 11th Annual AFRH Virtual Conference
Dr. Carlsson will be speaking on the topic of INVOcell® as an efficient, patient-centric fertility solution for the growing demand in AfricaSARASOTA, Fla., Sept. 3, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing...
INVO Bioscience Reports Second Quarter 2021 Financial and Operating Results and Provides Business Update
Company to Host Conference Call Today at 4:30pm ET (Details Below)SARASOTA, Fla., Aug. 16, 2021 -- INVO Bioscience, Inc. (Nasdaq: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of...
INVO Bioscience to Report Second Quarter 2021 Financial Results on Monday, August 16, 2021
Financial results to be released after market close; Conference call to be conducted at 4:30 pm ETSARASOTA, Fla., Aug. 5, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Culture System (IVC),...
INVO Bioscience Announces First Joint-Venture Grand Opening Scheduled for August 9, 2021 in Birmingham, Alabama
Innovative Fertility Specialists, An INVO Center becomes the first JV-owned clinic focused on providing INVOcell to assist the underserved patients in need of advanced fertility careSARASOTA, Fla., Aug. 2, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device...